COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA.
COVID-19
North Carolina
SARS-CoV-2
United States
coronavirus disease
respiratory infections
severe acute respiratory syndrome coronavirus 2
surveillance
symptoms
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
entrez:
27
12
2022
pubmed:
28
12
2022
medline:
29
12
2022
Statut:
ppublish
Résumé
In North Carolina, USA, the SARS-CoV-2 Omicron variant was associated with changing symptomology in daily surveys, including increasing rates of self-reported cough and sore throat and decreased rates of loss of taste and smell. Compared with the pre-Delta period, Delta and Omicron (pre-BA.4/BA.5) variant periods were associated with shorter symptom duration.
Identifiants
pubmed: 36573634
doi: 10.3201/eid2901.221111
pmc: PMC9796200
doi:
Banques de données
ClinicalTrials.gov
['NCT04342884']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
207-211Références
Lancet. 2021 Oct 16;398(10309):1407-1416
pubmed: 34619098
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915975
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915977
BMJ. 2021 Mar 17;372:n616
pubmed: 33731327
Nat Med. 2022 Sep;28(9):1933-1943
pubmed: 35675841
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Curr Opin Psychiatry. 2016 Sep;29(5):302-8
pubmed: 27427854
N Engl J Med. 2022 Jun 9;386(23):2243-2245
pubmed: 35507482
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1731-1734
pubmed: 34914670
Lancet Infect Dis. 2022 Jun;22(6):767-768
pubmed: 35429994
Nature. 2022 Mar;603(7902):706-714
pubmed: 35104837
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
Biol Methods Protoc. 2022 Nov 28;7(1):bpac033
pubmed: 36589317
Clin Infect Dis. 2022 Aug 03;:
pubmed: 35917440